CSIS WARRANT SERIES I vs Ikapharmindo Putramas Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp86 (market cap 4.6B, 1.3K 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp195 (market cap 330.19B, 215K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 71.8× CSIS WARRANT SERIES I's market cap, and Ikapharmindo Putramas Tbk. is more actively traded (215K versus 1.3K). Which is the better fit depends on your goals.
| CSIS-W | IKPM | |
|---|---|---|
Market Cap | 4.6B | 330.19B |
Volume | 1.3K | 215K |
Lot | 13 | 2.15K |
Turnover | 111.3K | 42.26M |
Average Price | 85.62 | 196.55 |
Value | 111.3K | 42.26M |
Indicative Equilibrium Price | — | 195 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →